Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ
This track focuses on the diagnostic challenges encountered in the spectrum of breast lesions, specifically from atypical ductal hyperplasia (ADH) to ductal carcinoma in situ (DCIS). With the increasing use of and detection techniques, the identification and accurate diagnosis of these lesions have become crucial for appropriate patient management. This track explores the complexities involved in distinguishing between ADH and DCIS, discussing the overlapping morphological features, immunohistochemical markers, and molecular characteristics that aid in differential diagnosis. The track also highlights the latest advancements in diagnostic tools, including genomic profiling and molecular testing, aiming to enhance diagnostic accuracy and guide optimal treatment strategies for patients with ADH and DCIS.
- Histopathological Evaluation: Morphological Criteria and Interpretation Challenges
- Radiological-Pathological Correlation: Enhancing Diagnostic Accuracy
- Biomarkers and Molecular Profiling: Identifying High-Risk Lesions
- Management Dilemmas: Overdiagnosis and Overtreatment
- Emerging Techniques and Technologies: Improving Diagnostic Precision
Related Conference of Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ
Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ Conference Speakers
Recommended Sessions
- Benign Breast Lesions: Diagnosis, Management, and Surveillance
- Biomarkers and Predictive Factors in Breast Pathology: Translating Research into Clinical Practice
- Breast Imaging: Innovations in Radiology and Pathology Correlation
- Breast Pathology in Pregnancy and Lactation: Challenges and Considerations
- Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ
- Emerging Technologies in Breast Pathology: Digital Pathology, AI, and Machine Learning
- Immunohistochemistry and Biomarkers in Breast Pathology
- Inflammatory Breast Cancer: Pathogenesis, Diagnosis, and Therapeutic Advances
- Metastatic Breast Cancer: Pathological Insights and Treatment Approaches
- Molecular Pathology: Unraveling Breast Cancer Subtypes
- Multidisciplinary Approach to Breast Pathology: Collaboration between Pathologists, Radiologists, Surgeons, and Oncologists
- Pathological Assessment of Breast Core Biopsies: Pitfalls and Best Practices
- Pathological Assessment of Breast Reconstruction: Challenges and Surgical Considerations
- Pathology of Triple-Negative Breast Cancer: Clinical Implications and Therapeutic Strategies
- Precision Medicine in Breast Pathology: Integrating Genomics and Targeted Therapies
Related Journals
Are you interested in
- Abdominal Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Advanced MRI Techniques in Oncology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Advancements in Early Detection and Precision Screening - Euro Breast Cancer 2026 (France)
- Advances in Immuno-Oncology and CAR-T Cell Therapies - CANCER2026 (France)
- Advances in Radiation Oncology - Euro Breast Cancer 2026 (France)
- AI & Machine Learning in Oncology - Cancer Summit 2026 (France)
- Artificial Intelligence and Digital Health in Breast Cancer - Breast Cancer Summit 2027 (France)
- Artificial Intelligence and Digital Innovations in Oncology - CANCER2026 (France)
- Artificial Intelligence and Emerging Technologies in Oncology - CANCER THERAPY MEETING 2027 (France)
- Artificial Intelligence in Cancer Radiology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Artificial Intelligence, Digital Health, and Big Data in Breast Cancer Care - Euro Breast Cancer 2026 (France)
- Biological Basis of Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Biomarker Discovery and Molecular Diagnostics in Cancer - CANCER2026 (France)
- Breast Cancer Awareness, Advocacy and Public Health - Breast Cancer Summit 2027 (France)
- Breast Cancer Biology and Tumor Microenvironment - Breast Cancer Summit 2027 (France)
- Breast Cancer During Pregnancy - Breast Cancer Summit 2027 (France)
- Breast Cancer in Young Women and Hereditary Syndromes - Euro Breast Cancer 2026 (France)
- Breast Cancer Prevention and Early Detection - Womens Health 2027 (France)
- Breast Cancer Prevention and Risk Assessment - Euro Breast Cancer 2026 (France)
- Breast Cancer Surgery and Reconstructive Oncology - Breast Cancer Summit 2027 (France)
- Breast Cancer, Cancer Therapies And Breast Cancer Treatment - Women Oncology-2026 (USA)
- Breast, Lung, Colorectal & Prostate Cancer Studies - Cancer Summit 2026 (France)
- Cancer & Biopsies - Cancer diagnostics 2026 (USA)
- Cancer Awareness and Survival - World Cancer-2026 (UAE)
- Cancer Biology - Women Oncology-2026 (USA)
- Cancer Biology & Tumor Microenvironment - Cancer Summit 2026 (France)
- Cancer Biology, Genetics and Epigenetics - CANCER THERAPY MEETING 2027 (France)
- Cancer Biomarker - Cancer diagnostics 2026 (USA)
- Cancer Biomarkers - Women Oncology-2026 (USA)
- Cancer Biomarkers and Molecular Diagnostics - CANCER THERAPY MEETING 2027 (France)
- Cancer Cell Biology & Genetics - World Cancer-2026 (UAE)
- Cancer Clinical Trails - Cancer diagnostics 2026 (USA)
- Cancer Development - Women Oncology-2026 (USA)
- Cancer Diagnostics Market - Cancer diagnostics 2026 (USA)
- Cancer Diagnostics Tools, Technologies and Procedures - Cancer diagnostics 2026 (USA)
- Cancer Drugs - Women Oncology-2026 (USA)
- Cancer Epidemiology - World Cancer-2026 (UAE)
- Cancer Epidemiology and Public Health - CANCER THERAPY MEETING 2027 (France)
- Cancer Epidemiology, Screening, Diagnosis & Prognosis - Women Oncology-2026 (USA)
- Cancer Genomics and Epigenetics - Cancer diagnostics 2026 (USA)
- Cancer Genomics, Epigenetics & Biomarkers - Cancer Summit 2026 (France)
- Cancer Health Disparities - Women Oncology-2026 (USA)
- Cancer Immunology & Immunotherapy - World Cancer-2026 (UAE)
- Cancer Immunotherapy and Immuno-Oncology - CANCER THERAPY MEETING 2027 (France)
- Cancer Immunotherapy and Immuno-Oncology - CANCER THERAPY MEETING 2027 (France)
- Cancer Immunotherapy and Types - Cancer diagnostics 2026 (USA)
- Cancer Nanotechnology - Cancer diagnostics 2026 (USA)
- Cancer Nanotechnology - World Cancer-2026 (UAE)
- Cancer Pharmacology - World Cancer-2026 (UAE)
- Cancer Prevention, Genetics and Risk Assessment - Breast Cancer Summit 2027 (France)
- Cancer Prevention, Lifestyle & Public Health - Cancer Summit 2026 (France)
- Cancer Prevention, Screening and Early Detection - CANCER THERAPY MEETING 2027 (France)
- Cancer Prevention, Screening, and Public Health Strategies - CANCER2026 (France)
- Cancer Preventive Vaccines: Oncolytic Therapy & Others - Women Oncology-2026 (USA)
- Cancer Radiology - Cancer diagnostics 2026 (USA)
- Cancer Research and Molecular Oncology - CANCER THERAPY MEETING 2027 (France)
- Cancer Risk Factors - Women Oncology-2026 (USA)
- Cancer Science - Women Oncology-2026 (USA)
- Cancer Screening and Diagnostic Innovation - Womens Health 2027 (France)
- Cancer Stem Cells - Women Oncology-2026 (USA)
- Cancer Stem Cells and Tumor Microenvironment - CANCER THERAPY MEETING 2027 (France)
- Cancer Survivorship and Rehabilitation - Womens Health 2027 (France)
- Cancer Treatment - Women Oncology-2026 (USA)
- Cancer Treatment and Therapeutic Developments - Womens Health 2027 (France)
- Cancer Treatment and Therapies - Cancer diagnostics 2026 (USA)
- Cancer vaccines - Women Oncology-2026 (USA)
- Cancer Vaccines and Therapeutics - Cancer diagnostics 2026 (USA)
- Cancer: Psychological & Social factors - World Cancer-2026 (UAE)
- Cancers & Stem Cell therapy - World Cancer-2026 (UAE)
- Cancers Biomarkers - World Cancer-2026 (UAE)
- Cancers Biopsy - World Cancer-2026 (UAE)
- Cancers Chemotherapy - World Cancer-2026 (UAE)
- Cancers Metabolomics - World Cancer-2026 (UAE)
- Cancers Metastasis - World Cancer-2026 (UAE)
- Cancers Prevention & Research - World Cancer-2026 (UAE)
- Cancers Therapy & Treatments - World Cancer-2026 (UAE)
- Cancers Vaccines - World Cancer-2026 (UAE)
- Cancers: lifestyle Connection and Nutrition - World Cancer-2026 (UAE)
- Cardio Oncology - Women Oncology-2026 (USA)
- Cell Cycle Regulation in Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Cellular Plasticity in Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Cellular Polarity and Asymmetric Division - Cancer Stem Cells 2027 (Italy)
- Cellular Stress Response in Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Cervical Cancer Prevention and HPV - Womens Health 2027 (France)
- Chemotherapy, Radiotherapy and Targeted Therapy - CANCER THERAPY MEETING 2027 (France)
- Chromatin Organization and Cellular Identity - Cancer Stem Cells 2027 (Italy)
- Circulating Tumor Cell (CTC) - Women Oncology-2026 (USA)
- Climate, Environment and Women's Health - Womens Health 2027 (France)
- Clinical Cancer research - Cancer diagnostics 2026 (USA)
- Clinical Oncology and Translational Cancer Research - CANCER THERAPY MEETING 2027 (France)
- Clinical Trials & Translational Cancer Research - Cancer Summit 2026 (France)
- Clinical Trials and Cancer Research - Womens Health 2027 (France)
- Clinical Trials and Innovative Therapeutic Approaches - CANCER THERAPY MEETING 2027 (France)
- Clinical Trials and Translational Research - Breast Cancer Summit 2027 (France)
- Clinical Trials, Drug Discovery, and Translational Research - Euro Breast Cancer 2026 (France)
- Complementary & Alternate Methods and Cancer - World Cancer-2026 (UAE)
- Digital Health and Artificial Intelligence - Womens Health 2027 (France)
- Digital Health, Telemedicine & Oncology Data Science - Cancer Summit 2026 (France)
- DNA Damage Response Mechanisms - Cancer Stem Cells 2027 (Italy)
- Early Cancer Detection and Liquid Biopsy Technologies - CANCER2026 (France)
- Early Detection, Screening & Diagnostic Technologies - Cancer Summit 2026 (France)
- Early Detection, Screening and Diagnosis - Breast Cancer Summit 2027 (France)
- Early-Onset Cancers in Women Under 50 - Womens Health 2027 (France)
- Emerging Therapies and Future Directions in Oncology - CANCER2026 (France)
- Emerging Trends and Future Perspectives in Cancer Research - CANCER THERAPY MEETING 2027 (France)
- Endometriosis, PCOS and Benign Gynaecological Conditions - Womens Health 2027 (France)
- Epigenetic Regulation in Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Epigenetics and Gene Editing in Cancer Therapy - CANCER2026 (France)
- Evolutionary Dynamics of Cancer Stem Cell Populations - Cancer Stem Cells 2027 (Italy)
- Future Directions in Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Future Innovations in Breast Cancer Research and Precision Medicine - Breast Cancer Summit 2027 (France)
- Gene Editing & CRISPR in Cancer - World Cancer-2026 (UAE)
- Genetic Instability and Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Genetic Mutations Of Cancer - Women Oncology-2026 (USA)
- Genetic Risk and Hereditary Cancers - Womens Health 2027 (France)
- Global Collaboration and Equitable Breast Cancer Care - Euro Breast Cancer 2026 (France)
- Global Oncology Trends and Future Perspectives - CANCER2026 (France)
- Gynecologic Oncology - Women Oncology-2026 (USA)
- Gynecologic Oncology and Cancer Care - Womens Health 2027 (France)
- Health Economics, Access, and Policy in Oncology - CANCER2026 (France)
- Hematologic Malignancies & Blood Cancers - Cancer Summit 2026 (France)
- Hematologic Malignancies and Blood Cancer Research - CANCER THERAPY MEETING 2027 (France)
- HER2-Positive and HER2-Low Breast Cancer - Euro Breast Cancer 2026 (France)
- Hormone Receptor-Positive Breast Cancer: Evolving Treatment Strategies - Euro Breast Cancer 2026 (France)
- Hybrid Imaging Technologies - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Hypoxia and Cancer Stem Cell Biology - Cancer Stem Cells 2027 (Italy)
- Image-Guided Interventional Oncology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Imaging-Guided Radiation Oncology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Immunotherapy & Targeted Therapy Advances - Cancer Summit 2026 (France)
- Immunotherapy and Emerging Cancer Therapies - Womens Health 2027 (France)
- Immunotherapy and Emerging Therapeutic Innovations - Breast Cancer Summit 2027 (France)
- Immunotherapy and Next-Generation Cancer Vaccines - CANCER2026 (France)
- Immunotherapy and Next-Generation Targeted Therapies - Euro Breast Cancer 2026 (France)
- Inflammation Driven Regulation of Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Innovations in Breast Cancer Surgery - Euro Breast Cancer 2026 (France)
- Intercellular Communication Within Tumors - Cancer Stem Cells 2027 (Italy)
- Lung Cancer in Women — The Overlooked Epidemic - Womens Health 2027 (France)
- Male Breast Cancer - Breast Cancer Summit 2027 (France)
- Maternal Health and Pregnancy Care - Womens Health 2027 (France)
- Menopause and Midlife Women's Health - Womens Health 2027 (France)
- Mental Health and Psycho-Oncology - Womens Health 2027 (France)
- Metabolic Characteristics of Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Metastasis, Tumor Progression and Angiogenesis - CANCER THERAPY MEETING 2027 (France)
- Metastatic Breast Cancer - Breast Cancer Summit 2027 (France)
- Metastatic Breast Cancer: Improving Survival and Quality of Life - Euro Breast Cancer 2026 (France)
- Migration and Invasive Properties of Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Molecular Imaging and Functional Oncology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Multidisciplinary Approaches and Integrated Cancer Care - CANCER2026 (France)
- Musculoskeletal Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Nanotechnology and Drug Delivery in Cancer Therapy - CANCER THERAPY MEETING 2027 (France)
- Nanotechnology and Drug Delivery Innovations in Cancer Therapy - CANCER2026 (France)
- Nanotechnology In Cancer Treatment - Women Oncology-2026 (USA)
- Neonatal & Pediatric Oncology - World Cancer-2026 (UAE)
- Neonatal And Pediatric Oncology - Women Oncology-2026 (USA)
- Neuro-Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Novel Anticancer Drugs and Drug Discovery - CANCER THERAPY MEETING 2027 (France)
- Novel Anticancer Drugs and Drug Discovery - CANCER THERAPY MEETING 2027 (France)
- Oncology Artificial Intelligence for Drug Discovery and Clinical Decision Support - CANCER2026 (France)
- Oncology Clinical Trials and Translational Research - CANCER2026 (France)
- Oncology Nursing - Women Oncology-2026 (USA)
- Oncology Nursing & Palliative Care - Cancer Summit 2026 (France)
- Oncology Nursing and Care - World Cancer-2026 (UAE)
- Oncology Nursing and Multidisciplinary Breast Cancer Care - Breast Cancer Summit 2027 (France)
- Oncology Research - Women Oncology-2026 (USA)
- Organ Specific Cancer - Women Oncology-2026 (USA)
- Organ-defined Cancers - World Cancer-2026 (UAE)
- Palliative Care, Cancer Survivorship and Quality of Life - CANCER THERAPY MEETING 2027 (France)
- Palliative, Supportive, and End-of-Life Care - Womens Health 2027 (France)
- Pediatric Oncology & Rare Cancers - Cancer Summit 2026 (France)
- Pediatric Oncology and Childhood Cancer Research - CANCER THERAPY MEETING 2027 (France)
- Pediatric Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- PET Imaging and Metabolic Oncology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Pharma Innovations & Drug Discovery in Oncology - Cancer Summit 2026 (France)
- Phases And Types Of Clinical Trails - Women Oncology-2026 (USA)
- Precision Cancers Medicinal Drug & Oncology - World Cancer-2026 (UAE)
- Precision Imaging for Early Cancer Identification - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Precision Medicine & Personalized Cancer Treatment - Cancer Summit 2026 (France)
- Precision Medicine And Immuno-Oncology - Women Oncology-2026 (USA)
- Precision Medicine and Personalized Cancer Treatment - CANCER THERAPY MEETING 2027 (France)
- Precision Oncology and Genomic Medicine - Euro Breast Cancer 2026 (France)
- Precision Oncology and Personalized Cancer Therapy - CANCER2026 (France)
- Precision Oncology for Women - Womens Health 2027 (France)
- Precision Oncology in Breast Cancer - Breast Cancer Summit 2027 (France)
- Predictive Cancer Biomarkers - Cancer diagnostics 2026 (USA)
- Public Awareness and Cancer Education - Womens Health 2027 (France)
- Pulmonary Oncology - Women Oncology-2026 (USA)
- Quiescence and Dormancy in Cancer Stem Cells - Cancer Stem Cells 2027 (Italy)
- Radiation Oncology - Women Oncology-2026 (USA)
- Radiation Oncology & Advanced Radiotherapy Techniques - Cancer Summit 2026 (France)
- Radiation Oncology and Precision Radiotherapy - Breast Cancer Summit 2027 (France)
- Radiologic Mapping of Tumor Microenvironments - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Radiology in Breast Oncology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Radiology in Cancer Survivorship - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Radiology in Immuno-Oncology - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Radiology in Surgical Oncology Planning - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Radiomics and Quantitative Image Analysis - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Radiotherapy Innovations and Precision Surgical Oncology - CANCER2026 (France)
- Recent Diagnostics Technologies - Cancer diagnostics 2026 (USA)
- Reproductive Health and Fertility Preservation - Womens Health 2027 (France)
- Role of the Tumor Microenvironment in Cancer Stem Cell Maintenance - Cancer Stem Cells 2027 (Italy)
- Self Renewal and Differentiation Mechanisms - Cancer Stem Cells 2027 (Italy)
- Stemness Gene Networks in Cancer - Cancer Stem Cells 2027 (Italy)
- Supportive Care, Palliative Oncology, and Patient-Centric Approaches - CANCER2026 (France)
- Surgical Oncology & Minimally Invasive Procedures - Cancer Summit 2026 (France)
- Surgical Oncology and Multidisciplinary Cancer Care - CANCER THERAPY MEETING 2027 (France)
- Survivorship, Rehabilitation, and Long-Term Care in Oncology - CANCER2026 (France)
- Survivorship, Rehabilitation, and Supportive Care - Euro Breast Cancer 2026 (France)
- Survivorship, Supportive Care and Quality of Life - Breast Cancer Summit 2027 (France)
- Targeted Therapies and Personalized Treatment Strategies - Breast Cancer Summit 2027 (France)
- Targeted Therapy and Molecular Oncology Advances - CANCER2026 (France)
- Tele-Oncology and Digital Health in Cancer Care - CANCER2026 (France)
- Thoracic Oncology Imaging - RADIOLOGY AND ONCOLOGY 2026 (Spain)
- Triple-Negative Breast Cancer: New Frontiers in Treatment - Euro Breast Cancer 2026 (France)
- Triple-Negative, HER2-Positive and Hormone Receptor-Positive Breast Cancer - Breast Cancer Summit 2027 (France)
- Tumor Cellular Heterogeneity and Stem Cell Hierarchy - Cancer Stem Cells 2027 (Italy)
- Tumor Virology, Immunology & Mobile Pathology - World Cancer-2026 (UAE)
- Types Of Cancers - Women Oncology-2026 (USA)
- Veterinary Oncology - Women Oncology-2026 (USA)
- Women's Cardiovascular and Metabolic Health - Womens Health 2027 (France)
- Women's Health Across the Life Course - Womens Health 2027 (France)
- Women's Health in Underserved Communities - Womens Health 2027 (France)
- Women's Microbiome, Gut Health and Hormonal Balance - Womens Health 2027 (France)